Radiation therapy is an indispensable tool in the fight against cancer, providing life-saving treatment for countless patients worldwide. However, a common side effect that significantly impacts patient comfort and quality of life is Radiation Dermatitis.

Understanding this critical challenge, Tecmed Pharma is proud to introduce StrataXRT, an innovative topical gel specifically developed to prevent and effectively treat Radiation Dermatitis, improving both clinical outcomes and patient wellbeing.

What is Radiation Dermatitis?

Radiation Dermatitis is an inflammatory skin reaction caused by exposure to radiation therapy. Symptoms can range from mild redness and irritation to severe blistering, peeling, and ulceration, significantly impacting patients’ quality of life and potentially interrupting their treatment schedules.

Introducing StrataXRT: A New Standard in Skin Protection

StrataXRT is an advanced topical gel designed explicitly for oncology patients undergoing radiation therapy. This innovative solution is engineered using a unique, flexible silicone-based formulation that creates a breathable, protective barrier over the skin, safeguarding it from radiation-induced damage.

How StrataXRT Works

• Protective Barrier: StrataXRT creates a flexible, durable, and breathable film that shields skin from external irritants and reduces transepidermal water loss, maintaining optimal hydration for healing.
• Symptom Management: Clinically proven to reduce pain, redness, inflammation, and the severity of skin reactions, thereby significantly improving patient comfort and treatment adherence.
• Ease of Use: A simple, once-daily application means StrataXRT easily integrates into treatment protocols, minimizing disruption to patient care routines.

Clinical Evidence and Applications

Recent clinical trials and studies have demonstrated StrataXRT’s remarkable efficacy:

• Reduction in severity and incidence of Radiation Dermatitis.
• Accelerated healing times compared to conventional treatments.
• Improved patient-reported outcomes including comfort, skin integrity, and overall satisfaction during radiation therapy.

StrataXRT is ideal for use across various oncology treatment regimens, particularly where radiation exposure to sensitive areas such as the breast, head and neck, and pelvic regions significantly increases dermatitis risk.

Benefits for Healthcare Providers and Patients

• Healthcare Providers: StrataXRT offers oncology teams an evidence-based solution that supports uninterrupted radiation treatment schedules and enhances overall patient care.
• Patients: Enhanced comfort, minimized skin reactions, and improved quality of life, allowing patients to complete their radiation therapy with fewer interruptions and complications.

Tecmed Pharma’s Commitment to Innovation

Tecmed Pharma remains dedicated to introducing innovative healthcare solutions that improve patient outcomes and enhance the efficacy of therapeutic procedures. With the launch of StrataXRT, we continue our commitment to supporting oncology care teams and their patients in achieving the best possible therapeutic results.

Discover more about StrataXRT and how Tecmed Pharma can support your radiation therapy protocols. For further information or to arrange a product demonstration, visit our website or contact our dedicated oncology support team today.